Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
martes, 16 de diciembre de 2025
ACUTE MIGRAINE (IHS)
ACUTE MIGRAINE (IHS)
•Initiating higher triptan doses
Acute Pharmacological Treatment of Migraine
Source: International Headache Society
https://reference.medscape.com/cc2/p10/international-headache-society-global-practice-2024a1000ieu?ecd=WNL_drugguide_251216_MSCPREF_neuro_etid7957108&uac=148436CN&impID=7957108
This Medscape summary of International Headache Society guidance covers practical, international, evidence-based recommendations from the International Headache Society on the acute pharmacological management of migraine.
Recommendations are categorised into two levels: optimal and essential. The optimal level is intended for settings where most drug treatments are available. The essential level is intended for underserved areas, where treatment options are limited or that can only count on the medications listed in the World Health Organization (WHO) model list of essential medicines (EML).
•Combining triptans and NSAIDs
https://reference.medscape.com/cc2/p10/international-headache-society-global-practice-2024a1000ieu?ecd=WNL_drugguide_251216_MSCPREF_neuro_etid7957108&uac=148436CN&impID=7957108
•Treatment of early vomiting
https://reference.medscape.com/cc2/p10/international-headache-society-global-practice-2024a1000ieu?ecd=WNL_drugguide_251216_MSCPREF_neuro_etid7957108&uac=148436CN&impID=7957108
No hay comentarios:
Publicar un comentario